Pancreatic islet cells: Phase III data

Top-line data from an open-label, U.S. and Canadian Phase III trial in 48 Type I diabetics with persistent impaired awareness of hypoglycemia who had experienced hypoglycemic events despite physician

Read the full 292 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE